Company / Depreciation & Amortization
Biohaven Ltd. Depreciation & Amortization History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$7.9M
FY2024
5-year range
$72.0K / $7.9M
FY2020-FY2024
Trend
+13.6%
vs FY2023
Sector context
#72 of 163
Health Care
What the data says
At $8M, Biohaven Ltd.'s depreciation & amortization ranks #92 of 163 in the Health Care sector. Increased from $1M to $8M over the past 2 years.
Based on SEC 10-K filings.
$8M in FY2024 with a 3-year CAGR of +78.0%.
Increased from $1M to $8M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +78.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#92 of 163 in Health CareTop 56% of 163This company $7.9M Sector average $219.4M
▼
-96.4% below sector average
Key checks
Key Insights
- 3-year CAGR of +78.0%, indicating consistent growth.
- In FY2024, depreciation & amortization increased 13.6% year-over-year.
- Ranks #72 out of 163 companies in the Health Care sector.
- Lowest depreciation & amortization in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $7.9M | +13.6% |
| FY2023 | $6.9M | +398.7% |
| FY2022 | $1.4M | -0.5% |
| FY2021 | $1.4M | +1834.7% |
| FY2020 | $72.0K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026